Refine your search with filters

All-Materials All
Congress-AbstractsCongress Abstracts
Tools-SkillsTools & Skills
PublicationsPublications
Congress-SlidesCongress Presentations
Videos-PodcastsVideos & Podcasts

Quicksearch

P224: Primary sclerosing cholangitis in the Swiss Inflammatory Bowel Disease Cohort: prevalence, risk factors, and long-term follow-upECCO '16 Amsterdam
Year: 2016
Authors:

M. Fraga*1, N. Fournier2, E. Safroneeva3, V. Pittet4, A. Nydegger5, S. Vavricka6, D. Moradpour1, A. Schoepfer1

1CHUV - Centre Hospitalier Universitaire Vaudois, Department of Gastroenterology and Hepatology, Lausanne, Switzerland, 2Institute for Social and Preventive Medicine, Healthcare Evaluation Unit, Lausanne, Switzerland, 3Institute of Social and Preventive Medicine, Division of Clinical Epidemiology and Biostatics, University of Bern, Bern, Switzerland, 4Institute For Social And Preventive Medicine, Health Care Evaluation Unit, Lausanne, Switzerland, 5Centre Hospitalier Universitaire Vaudois CHUV, Unité de Gastroentérologie / Nutrition pédiatrique, Lausanne, Switzerland, 6Stadtspital Triemli, Department of Gastroenterology and Hepatology, Zurich, Switzerland

P225: Cross-sectional evaluation of transmural healing in patients with Crohn’s disease on maintenance treatment with biologicsECCO '16 Amsterdam
Year: 2016
Authors:

A. Testa*1, A. Rispo1, P. Mainenti2, N. Imperatore1, G. D. De Palma1, M. Rea1, F. Maione1, O. M. Nardone1, M. L. Taranto1, F. Castiglione1

1University ‘Federico II’ of Naples, Department of Clinical Medicine and Surgery, Naples, Italy, 2University ‘Federico II’ of Naples, Naples, Italy

P226: The first validated post-operative endoscopic Crohn’s disease index: the POCER index— identification of key endoscopic prognostic factorsECCO '16 Amsterdam
Year: 2016
Authors:

P. De Cruz*1, 2, M. Kamm1, A. Hamilton2, K. Ritchie3, A. Gorelik2, D. Liew2, I. Lawrance4, J. Andrews5, P. Bampton6, P. Gibson7, M. Sparrow7, R. Leong8, T. Florin9, R. Gearry10, G. Radford-Smith9, F. Macrae2, H. Debinski11, W. Selby12, I. Kronborg1, M. Johnston13, R. Woods14, R. Elliott3, S. Bell3, S. Brown3, W. Connell3, P. Desmond3

1University of Melbourne, Gastroenterology, Melbourne, Australia, 2University of Melbourne, Medicine, Melbourne, Australia, 3St Vincent’s University Hospital, Department of Gastroenterology, Melbourne, Australia, 4University of Western Australia, Gastroenterology, Perth, Australia, 5University of Adelaide, Adelaide, Australia, 6Flinders University, Gastroenterology, Flinders, Australia, 7Monash University, Gastroenterology, Melbourne, Australia, 8University Of Sydney, Concord Repatriation General Hospital, Department of Gastroenterology, Sydney, Australia, 9Queensland Institute of Medical Research, Medicine, Brisbane, Australia, 10University of Otago, Christchurch, Department of IBD, Gastroenterology, Christchurch, New Zealand, 11Monash University, Medicine, Melbourne, Australia, 12University of New South Wales, Gastroenterology, Sydney, Australia, 13St Vincent’s University Hospital, Department of Colorectal Surgery, Melbourne, Australia, 14St Vincent’s University Hospital, Department of Colorectal Surgery, Melbourne, Australia, Melbourne, Australia

P227: Faecal calprotectin reductions in patients achieving mucosal healing with vedolizumab induction therapy in GEMINI 1ECCO '16 Amsterdam
Year: 2016
Authors:

J. D. Lewis*1, W. Reinisch2, B. Bressler3, A. Parikh4, H. Yang5, M. Rosario5, A. Roseth6, S. Danese7, B. G. Feagan8, B. E. Sands9, P. Ginsburg10, T. Dassopoulos11, J. Xu5, T. Wyant5

1University of Pennsylvania Perelman School of Medicine, Gastroenterology, Philadelphia, Pennsylvania, United States, 2Univ. Klinik für Innere Medizin III, Vienna, Austria & McMaster University, Hamilton, Ontario, Canada, 3University of British Columbia, Vancouver, BC, Canada, 4Takeda Pharmaceuticals International, Inc, Deerfield, Illinois, United States, 5Takeda Pharmaceuticals International Co, Cambridge, Massachusetts, United States, 6Lovisenberg Diaconal Hospital, Oslo, Norway, 7IBD Centre, Istituto Clinico Humanitas, Milan, Italy, 8Robarts Research Institute, University of Western Ontario, Clinical Trials, London, Ontario, Canada, 9Icahn School of Medicine at Mount Sinai Hospital, New York, New York, United States, 10Gastroenterology Centre of Connecticut, Hamden, Connecticut, United States, 11Gastroenterology Division, Washington University School of Medicine, St. Louis, Missouri, United States

P228: Prevalence of malnutrition and nutritional characteristics of patients with inflammatory bowel diseaseECCO '16 Amsterdam
Year: 2016
Authors:

M. Casanova*1, M. Chaparro1, B. Molina2, O. Merino3, O. Nuevo-Siguairo4, C. Dueñas-Sadornil5, A.M. García-Albert6, D. Hervías7, X. Calvet8, L. Bujanda9, G.E. Rodríguez10, M. Montoro11, L. Castro-Laria12, M. Barreiro-de Acosta13, M. Van Domselaar14, J. M. Huguet15, P. Ramírez de la Piscina16, J. Barrio17, A. Algaba18, A. D. Ávila19, S. Torra20, L. Pozzati21, F. J. Martínez-Cerezo22, M. Calvo23, M. Charro24, P. López-Serrano25, M. R. Arribas-López26, M. Muñoz Vicente27, M. L. Rincón28, A. C. Peláez29, E. Castro30, A. García-Herola31, R. Batanero32, A. Castaño-García33, P. Robledo-Andrés34, M. B. Gómez-Sánchez35, A. Figuerola36, J. M. Banales37, L. Díaz-Hernández10, I. Vázquez38, F. Arguelles-Arias12, E. Marti-Bonmati39, F. Bermejo18, P. Serrano40, I. Megias-Rangil41, M. Campderá42, A. Barragán43, A. Merchante44, J. P. Gisbert1

1Hospital Universitario de La Princesa, IIS-IP and CIBERehd, Gastroenterology Unit, Madrid, Spain, 2Hospital Universitario de La Princesa, IIS-IP and CIBERehd, Endocrinology Unit, Madrid, Spain, 3Hospital Universitario de Cruces, Gastroenterology Unit, Bilbao, Spain, 4Hospital Central de Asturias, Gastroenterology unit, Oviedo, Spain, 5Hospital San Pedro de Alcántara, Gastroenterology Unit, Cáceres, Spain, 6Hospital Universitario Reina Sofía, Gastroenterology Unit, Murcia, Spain, 7Hospital Virgen de la Altagracia, Gastroenterology Unit, Manzanares, Spain, 8Corporació Sanitària Parc Taulí and CIBERehd, Gastroenterology Unit, Sabadell, Spain, 9Hospital de Donostia, Instituto Biodonostia, UPV/EHU and CIBEREHD, Gastroenterology Unit, Guipuzcoa, Spain, 10Hospital Universitario Nuestra Señora de La Candelaria, Gastroenterology Unit, Tenerife, Spain, 11Hospital San Jorge, Gastroenterology Unit, Huesca, Spain, 12Hospital Universitario Virgen de La Macarena, Gastroenterology Unit, Sevilla, Spain, 13Hospital Clínico Universitario de Santiago, Gastroenterology Unit, Santiago de Compostela, Spain, 14Hospital de Torrejón, Gastroenterology Unit, Madrid, Spain, 15Consorcio Hospital General Universitario de Valencia, Gastroenterology Unit, Valencia, Spain, 16Hospital Universitario de Alava, Gastroenterology Unit, Vitoria, Spain, 17Hospital Universitario Rio Hortega, Gastroenterology Unit, Valladolid, Spain, 18Hospital Universitario de Fuenlabrada, Gastroenterology Unit, Madrid, Spain, 19Hospital Universitario Virgen del Rocío, Gastroenterology Unit, Sevilla, Spain, 20Parc Sanitari Sant Joan de Déu, Gastroenterology Unit, Barcelona, Spain, 21Hospital de Mérida, Gastroenterology Unit, Mérida, Spain, 22Hospital Universitario Sant Joan de Reus, Gastroenterology Unit, Tarragona, Spain, 23Hospital Universitario Puerta de Hierro, Gastroenterology Unit, Madrid, Spain, 24Hospital Royo Villanova, Gastroenterology Unit, Zaragoza, Spain, 25Hospital Universitario Fundación Alcorcón, Gastroenterology Unit, Madrid, Spain, 26Hospital Universitario Infanta Sofía, Gastroenterology Unit, Madrid, Spain, 27Hospital General Universitario de Castellón, Gastroenterology Unit, Castellón, Spain, 28Hospital Comarcal Bidasoa, Gastroenterology Unit, Guipúzkoa, Spain, 29Hospital General de Catalunya, Gastroenterology Unit, Barcelona, Spain, 30Hospital Lucus Augusti, Gastroenterology Unit, Lugo, Spain, 31Hospital Marina Baixa, Gastroenterology Unit, Alicante, Spain, 32Hospital Universitario de Cruces, Endocrinology Unit, Bilbao, Spain, 33Hospital Central de Asturias, Gastroenterology Unit, Oviedo, Spain, 34Hospital Universitario San Pedro Alcántara, Gastroenterology Unit, Cáceres, Spain, 35Hospital Universitario Reina Sofía, Endocrinology Unit, Murcia, Spain, 36Hospital de Sabadell. Institut Universitari ParcTaulí and CIBERehd, Gastroenterology Unit, Sabadell, Spain, 37Hospital de Donostia, Endocrinology Unit, Donostia, Spain, 38Hospital San Jorge, Endocrinology Unit, Huesca, Spain, 39Hospital General Universitario de Valencia, Pharmacy Unit, Valencia, Spain, 40Hospital Universitario Virgen del Rocío, Endocrinology Unit, Sevilla, Spain, 41Hospital Universitario Sant Joan de Reus, Endocrinology Unit, Tarragona, Spain, 42Hospital Universitario Puerta de Hierro, Endocrinology Unit, Madrid, Spain, 43Hospital Royo Villanova, Endocrinology Unit, Zaragoza, Spain, 44Hospital General Universitario de Castellón, Endocrinology Unit, Castellón, Spain

P229: Evidence of content validity and psychometric properties of SF-36 for measuring health-related quality of life of patients with Crohn’s diseaseECCO '16 Amsterdam
Year: 2016
Authors:

A. Yarlas1, M. White1, M. Ingham2, D. Naessens*3, C. Han3

1Optum, Lincoln, Nebraska, United States, 2Janssen Scientific Affairs, LLC, Horsham, Pennsylvania, United States, 3Janssen Pharmaceutica NV, Beerse, Belgium

P230: Elevated angiopoietins independent of TNF α regulation appear to play a key role in immune mediated angiogenesis in inflammatory bowel diseaseECCO '16 Amsterdam
Year: 2016
Authors:

M. Hussey*1, G. Holleran1, K. Grooteman2, S. Smith3, D. McNamara1

1Adelaide and Meath Hospital, Trinity College Dublin, Gastroenterology, Trinity Academic Gastroenterology Group, Dublin, Ireland, 2Radboud University Medical Centre, Department of Gastroenterology, Nijmegen, Netherlands, 3Trinity College Dublin, Clinical Medicine, Trinity Academic Gastroenterology Group, Dublin, Ireland

P231: Development of a small bowel capsule endoscopic index of severity in patients with Crohn’s diseaseECCO '16 Amsterdam
Year: 2016
Authors:

A. Bourreille*1, A. Attar2, V. Maunoury3, M. Simon4, A. Aubourg5, M. Fumery6, J.-M. Reimund7, C. Reenaers8, I. Nion-Larmurier2, B. Bonaz9, J. Filippi10, O. Dewit11, X. Dray2, J. Moreau12, R. Altwegg13, X. Roblin14, C. Stefanescu2, J.-y. Mary15

1CHU Nantes, Institut des Maladies de l’Appareil Digestif, Nantes, France, 2CHU Paris, Gastroenterologie, Paris, France, 3CHU Lille, Gastroenterologie, Lille, France, 4CHU, Gastroenterologie, Paris, France, 5CHU Tours, Gastroenterologie, Tours, France, 6CHU Amiens, Gastroentérologie, Amiens, France, 7CHU Caen, Gastroenterologie, Caen, France, 8CHU Liège, Gastroenterologie, Liège, Belgium, 9CHU Grenoble, Gastroenterologie, Grenoble, France, 10CHU Nice, Gastroenterologie, Nice, France, 11CHU Bruxelles, Gastroenterologie, Bruxelles, Belgium, 12CHU toulouse, Gastroenterologie, Toulouse, France, 13CHU Montpellier, Gastroenterologie, Montpellier, France, 14CHU Saint Etienne, Gastroenterologie, Saint Etienne, France, 15Inserm, Biostatistique, Paris, France

P232: Paediatric Crohn’s disease and its disability over time: a study performed with a new paediatric Lemann Index: preliminary data from a tertiary Paediatric IBD centreECCO '16 Amsterdam
Year: 2016
Authors:

G. Bodini*1, S. Arrigo2, A. Bizzocchi2, E. G. Giannini1, V. Savarino1, E. Savarino3, A. Barabino2

1University of Genoa, Internal Medicine Department, Genoa, Italy, 2G. Gaslini Institute, Paediatric Gastroenterology and Endoscopy, Genoa, Italy, 3University of Padua, Gastroenterology Unit, Department of Surgery, Oncology and Gastroenterology, Padua, Italy

P233: Management of patients with quiescent Crohn’s disease based on Capsule Endoscopy Crohn’s Disease Activity IndexECCO '16 Amsterdam
Year: 2016
Authors:

T. Omori*, B. Iizuka, H. Kashiwagi, T. Hara, T. Kuriyama, A. Ito, M. Yonezawa, K. Tokushige

Tokyo Women’s Medical University, Gastroenterology, Tokyo, Japan

P234: The diagnostic yield of small bowel capsule endoscopy in postsurgical Crohn’s diseaseECCO '16 Amsterdam
Year: 2016
Authors:

N. Viazis*, L. Varitimiadis, M. Galanopoulos, A. Tsigaridas, M. Chanias, S. Anastasiadis, I. Tziortziotis, C. Pontas, E. Tsoukali, P. Karatzas, D. Karamanolis

Evangelismos Hospital, Gastroenterology Department, Athens, Greece

P235: The association between serum vitamin D status and disease activity in paediatric inflammatory bowel diseaseECCO '16 Amsterdam
Year: 2016
Authors:

E. O’Neill*1, T. Raftery2, A. M. Broderick2, B. Bourke2, S. Hussey2

1University College Dublin, Dublin 4, Ireland, 2Our Lady’s Children’s Hospital Crumlin, Gastroenterology, Dublin, Ireland

P236: Faecal calprotectin is a poor predictor of irritable bowel disease relapse during pregnancyECCO '16 Amsterdam
Year: 2016
Authors:

S. Kanis*, A. de Lima, V. van Oorschot, C. van der Woude

Erasmus Medical Centre, Gastroenterology and Hepatology, Rotterdam, Netherlands

P237: Ionising radiation exposure in patients with Crohn´s disease: estimation and risk factorsECCO '16 Amsterdam
Year: 2016
Authors:

M. Barbosa*1, T. Gonçalves1, M. J. Moreira1, J. Cotter1, 2, 3

1Hospital da Senhora da Oliveira, Gastroenterology, Guimarães, Portugal, 2Instituto de Investigação em Ciências da Vida e da Saúde, Universidade do Minho, Braga, Portugal, 3Laboratório Associado ICVS/3B´s, Braga, Portugal

P238: Vitamin D deficiency in inflammatory bowel disease: is malabsorption to blame?ECCO '16 Amsterdam
Year: 2016
Authors:

J. Schembri*, S. Chetcuti, S. Vella, P. Ellul

Mater Dei Hospital, Gastroenterology, Msida, Malta

P239: Hospitalisations and characteristics of patients with ulcerative colitis and Crohn’s disease treated with vedolizumab in real-world clinical practice: results from a multicentre studyECCO '16 Amsterdam
Year: 2016
Authors:

M. Reynolds1, N. Alam2, M. Raluy2, B. Gardstein1, D. O’Hara3, M. Smyth4, J. M. Khalid*4

1Evidera, Lexington, United States, 2Evidera, Hammersmith, United Kingdom, 3Evidera, San Francisco, United States, 4Takeda, London, United Kingdom

P240: Microscopic colitis, are there any predictors?ECCO '16 Amsterdam
Year: 2016
Authors:

I. G. Moraru*1, R. Vadan1, L. Gheorghe2, M. Dumbrava3, G. Becheanu3

1Third Department of Gastroenterology, Clinical Hospital Fundeni, Bucarest, Gastroenterology, Bucarest, Romania, 2Third Department of Gastroenterology, Clinical Hospital Fundeni, Bucarest, Hepatology, Bucarest, Romania, 3Third Department of Gastroenterology, Clinical Hospital Fundeni, Bucarest, Anatomical Pathology, Bucarest, Romania

P241: Risk factors associated with perianal Crohn’s disease in Korean childrenECCO '16 Amsterdam
Year: 2016
Authors:

E. Ryoo*, K. Lim, H. Tchah

Gachon University, Gil Hospital, Paediatrics, Incheon, South Korea

P242: Performance of the BÜHLMANN Quantum Blue® Infliximab point-of-care assay dedicated for therapeutic drug monitoring of serum infliximab trough levelsECCO '16 Amsterdam
Year: 2016
Authors:

T. Schuster*, E. Keller, S. Kräuchi, F. Bantleon, J. Weber, M. Schneider

BÜHLMANN Laboratories AG, Schönenbuch, Switzerland

P243: Developing a protocol to conduct a student-driven study across Europe: EuroSurg-1 studyECCO '16 Amsterdam
Year: 2016
Authors:

G. Pellino on behalf of EuroSurg Collaborative*

Second University of Naples, Unit of Colorectal Surgery, Naples, Italy